Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02991911
Title A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

prostate adenocarcinoma

Therapies

Enzalutamide + MEDI3726

MEDI3726

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.